Review confirms early diagnosis tool

February, 2010

A comprehensive survey confirms the value of an early diagnostic tool, and provides strong evidence for the central importance of amyloid-beta protein plaques in the development of Alzheimer’s.

A survey of more than 100 studies involving PIB-PET, a diagnostic tool that involves injecting a radiotracer called Pittsburgh compound B into the brain via the bloodstream, and imaging the brain with positron emission tomography (PET), has confirmed its sensitivity in detecting amyloid-beta protein plaques. The tool is not yet commercially available. The study also provides strong evidence supporting the theory that accumulation of amyloid-beta protein plaques in the brain is central to the development of Alzheimer’s. The findings, that amyloid deposits appear to reach a plateau early in the disease course, may explain why Alzheimer's patients have not responded to promising experimental drugs that target amyloid. It may be that they are being administered too late.

http://www.eurekalert.org/pub_releases/2010-02/uoc--nsm020910.php

Reference:

[182] Rabinovici, G. D., & Jagust W. J.
(2009). Amyloid imaging in aging and dementia: Testing the amyloid hypothesis in vivo.
Behavioural Neurology. 21(1), 117 - 128.

seniors

alzheimers-diagnosis

Alzheimers

Related News

Alzheimer's memory problems originate with oligomers not plaques

While everyone agrees that amyloid-beta protein is part of the problem, not everyone agrees that amyloid plaques are the cause (or one of them) of Alzheimer’s. Other forms of amyloid-beta have been pointed to, including floating clumps called oligomers or ADDLs.

More evidence for benefits of Rapamycin

A few months ago, I reported on an exciting finding that

New guideline on when people with Alzheimer's disease should stop driving

The American Academy of Neurology has updated its guidelines on when people with dementia should stop driving.

New gene associated with increased risk of Alzheimer's

Another gene has been identified that appears to increase risk of Alzheimer’s. The gene, MTHFD1L, is located on chromosome six.

Losing muscle mass early sign of Alzheimer’s

Previous research has found that unexplained weight loss is an early sign of Alzheimer's.

Memory problems not the only predictor of later mild cognitive impairment

Amnestic mild cognitive impairment often leads to Alzheimer's disease, but what predicts aMCI?

Apple juice improves behavior in Alzheimer's patients

A pilot study involving 21 institutionalized individuals with moderate-to-severe Alzheimer’s found that, although drinking two 4-oz glasses of apple juice daily for a month produced no change in the Dementia Rating Scale or in the Activities of Daily Living measure, there was a significant (27%)

TMS improves language comprehension in Alzheimer's sufferers

A pilot study involving 10 patients with moderate Alzheimer's disease, of whom half were randomly assigned to the treatment, has found that two weeks of receiving daily (25 minute) periods of repetitive transcranial magnetic stimulation to the prefrontal

Common Alzheimer's medication helps skills necessary for safe driving

A study involving outpatients with early stage Alzheimer’s found that their performance on some computerized tests of executive function and visual attention, including a simulated driving task, improved significantly after three months of taking

Cognitive ability, not age, predicts risky decisions

A study involving 54 older adults (66-76) and 58 younger adults (18-35) challenges the idea that age itself causes people to become more risk-averse and to make poorer decisions.

Pages